Addiction

Driven to End Addiction

The University of Minnesota's Medical Discovery Team (MDT) on Addiction is a multidisciplinary initiative within the University of Minnesota’s Medical School to advance research and treatment in the field of drug addiction. The overarching goal of the Medical Discovery Team on Addiction is to link brain-based discoveries to new therapeutic approaches to treat or prevent addiction.

The MDT on Addiction is one of four MDTs created to support the Medical School's efforts to increase national preeminence by attracting and retaining world-class faculty, staff, students, and residents. As well as, achieve the state's goals of improving patient and population health, lowering costs and improving health care experiences.

 

Pravetoni lab by Goldy statue

Meet our cross-disciplinary team of researchers and clinician-scientists dedicated to the study and treatment of addiction.

scan of CortexDSProjections

Learn about our team’s collaborative, interdisciplinary research aimed at transforming how we view and treat addiction.

Group photo with Andrew Zimmern

Learn more about how we engage with the public, and how you can support our work.

Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), contacted the UMN to visit with students and faculty while he was in Minneapolis last week.  As director of the ONDCP, Dr.

Cece is investigating agmatine, a mild NMDAR antagonist, that has been shown to mitigate the rewarding properties of opioids while still providing pain relief.

Article

Funded teams each received $100,000 to support their proposed research in addiction science.

Awards

Arif Hamid, PhD, and a Howard Hughes Gray fellow has joined the University of Minnesota’s Medical Discovery Team on Addiction (MDTA).

Article
Upcoming Events